Investigation of Gpx1 in chondrogenesis and its role on redox regulation in chondrocytes by Koretsi, Vasiliki
AUS DEM LEHRSTUHL 
FÜR KIEFERORTHOPÄDIE 
PROF. DR. DR. P. PROFF 
DER FAKULTÄT FÜR MEDIZIN 
DER UNIVERSITÄT REGENSBURG  
 
 
Investigation of Gpx1 in chondrogenesis and its role on redox regulation in 
chondrocytes 
 
 
 
Inaugural – Dissertation 
zur Erlangung des Doktorgrades 
der Zahnmedizin 
 
 
der 
Fakultät für Medizin 
der Universität Regensburg 
 
vorgelegt von 
Vasiliki Koretsi 
 
2015 
 
  
 - 1 - 
AUS DEM LEHRSTUHL 
FÜR KIEFERORTHOPÄDIE 
PROF. DR. DR. P. PROFF 
DER FAKULTÄT FÜR MEDIZIN 
DER UNIVERSITÄT REGENSBURG  
 
 
Investigation of Gpx1 in chondrogenesis and its role on redox regulation in 
chondrocytes 
 
 
 
Inaugural – Dissertation 
zur Erlangung des Doktorgrades 
der Zahnmedizin 
 
 
der 
Fakultät für Medizin 
der Universität Regensburg 
 
vorgelegt von 
Vasiliki Koretsi 
 
2015 
 
 - 2 - 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Dekan: Prof. Dr. Dr. Torsten Reichert 
1. Berichterstatter: Prof. Dr. Dr. Peter Proff 
2. Berichterstatter: Prof. Dr. Michael Behr 
Tag der mündlichen Prüfung: 05.07.2016 
 
 - 3 - 
Table of contents 
 
1. Statement of the problem and objectives 5 
2. Review of the literature 6 
2.1. The cranial base 6 
2.1.1. Developmental and anatomical aspects 6 
2.1.2. The growth of the cranial base and its implications in facial shape 8 
2.1.3. Angulation of cranial base and occlusal type 12 
2.2. The process of endochondral ossification 13 
2.2.1. Early differentiation of chondrocytes 13 
2.2.2. Terminal differentiation of chondrocytes and endochondral ossification 17 
2.3. The role of reactive oxygen species and antioxidants on endochondral  
ossification 19 
2.4. Glutathione peroxidase 1 22 
3. Materials and methods 24 
3.1. Materials 24 
3.2. Methods 33 
3.2.1. Culture conditions 33 
3.2.2. Isolation of RNA 35 
3.2.3. Reverse transcription 36 
3.2.4. Quantitative Real Time-PCR 36 
3.2.5. Stains 39 
3.2.6. Immunohistochemistry 39 
3.2.7. Overexpression and silencing of Gpx1 41 
 - 4 - 
3.2.8. Western blotting 43 
3.2.9. Exposure to H2O2 and apoptosis assay 46 
3.2.10. Statistical analysis 46 
4. Results 48 
4.1. Chondrogenic differentiation of the ATDC5 cell line 48 
4.1.1. Stains 48 
4.1.2. Expression of biological markers of chondrogenic differentiation 49 
4.2. Expression pattern of Gpx1 in vitro 50 
4.3. Localization of Gpx1 expression at the spheno-occipital synchondrosis 51 
4.4. Apoptosis assay after exogenous exposure to H2O2 53 
5. Discussion 55 
5.1. Expression of Gpx1 during chondrogenic differentiation 55 
5.2. Hypertrophic chondrocytes have the lowest Gpx1-immunoreactivity 57 
5.3. Gpx1 plays a vital role on H2O2-induced apoptosis in chondrocytes 58 
6. Summary 60 
7. Zusammenfassung 62 
8. References 64 
List of figures  
List of tables  
List of abbreviations  
Declaration of academic honesty / Eidesstattliche Erklärung  
Acknowledgements  
 
  - 5 - 
1. Statement of the problem and objectives 
 
The development of cranial base exerts a great influence on the overall facial shape. In the 
vertical plane, the inclination of the middle cranial fossa affects the position of the 
nasomaxillary complex in relation to the mandible, thus; influencing the vertical growth of the 
face. A hypodivergent growth pattern may be due to a forward-downward inclination of the 
middle cranial fossa, whereas a hyperdivergent growth pattern may be a resultant of 
posterosuperior inclination of it. Sagittally, Class II skeletal malocclusion is often 
characterized by one or more of the following: an elongated posterior cranial fossa, a forward 
and downward position of it, a short composite of ramus and the vertical dimension of 
posterior cranial fossa, and a more open cranial base flexure. By contrast, Class III skeletal 
malocclusions often demonstrate a size reduction in the posterior cranial base, a backward 
alignment of it, a long composite of ramus and the vertical dimension of the posterior cranial 
fossa, and a relative acute cranial base angle (Enlow and Hans, 1996; Premkumar, 2011). 
The process of endochondral ossification characterizes both the development and growth of 
the cranial base. It is the mechanism by which the cranial base develops from the 
chondrocranium to the basicranium and also grows at the midline axis postnatally. The 
midline axis of the cranial base is the region where all the synchondroses are located. It 
contributes significantly both to elongation and angulation of the cranial base (Sperber, 1989; 
Proffit et al., 2007). The process of endochondral ossification has been studied extensively. 
However, it was not until recently that the fundamental role of reactive oxygen species (ROS) 
was revealed and documented. In particular, hydrogen peroxide (H2O2) causes inhibition of 
proliferating chondrocytes and is required for the normal differentiation of proliferating to 
hypertrophic chondrocytes (Morita et al., 2007). 
The antioxidant enzyme glutathione peroxidase 1 (Gpx1) can efficiently reduce H2O2 (Mills, 
1957). Provided that no previous research has been undertaken to elucidate the role of Gpx1 
on chondrogenic differentiation, the objectives of this study (Koretsi et al., 2015) were:  
 Observation and definition of the temporal expression pattern of Gpx1 during 
chondrogenic differentiation in vitro. 
 Identification of Gpx1 expression according to the different stages of chondrogenic 
differentiation. 
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 Determination of Gpx1 as an antioxidant enzyme capable of regulating redox state in 
chondrocytes. 
  
2. Review of the literature 
 
2.1. The cranial base 
 
Cranial base is the oldest part of the human skull phylogenetically. It is an integrative 
component of the skull that serves several functions (Enlow, 1968; Stark, 1975; Knußmann, 
1988; Sperber, 2001). It serves as a platform, upon which the brain grows, and provides a 
thrust for the anterior growth of the facial skeleton. In addition, the cranial base connects the 
cranium with the rest of the body (articulation with the vertebral column, maxillary region 
and the mandible, provision of conduits for all the vital neural and circulatory connections, 
formation of the roof of the nasopharynx) (Premkumar, 2011). 
 
2.1.1. Developmental and anatomical aspects 
 
The human cranial base first appears in the second month of embryonic life as an irregular 
cartilaginous shape, the chondrocranium. The chondrocranium develops as condensations of 
the neural crest cells and paraxial mesoderm in the ectomeninx (Sperber, 1989). Nine groups 
of paired cartilaginous precursors are subsequently formed by the growth and differentiation 
of the ectomeninx (Kjaer, 1990; Fig. 1). 
The cartilaginous precursors anterior to the notochord derive solely from segmented neural 
crest tissue, similar to other facial bones; while the posterior precursors derive from 
segmented mesodermal tissue. By this means, the middle of the sphenoid body marks the 
division between the anterior and posterior portions of the cranial base, which have distinct 
embryologic origins; the anterior cranial base stemming from the neural crest and the 
posterior from the paraxial mesoderm (Noden, 1991; Couly et al., 1993; Le Douarin et al., 
1993). 
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Via endochondral ossification from numerous ossification centres, which form a highly 
perforated irregular mass of cartilages known as basal plate, the chondrocranium is 
transformed to the basicranium. The proceeding of ossification is initiated from the 
mesodermally derived cartilages and moves from caudal to rostral and lateral; finally 
composing the four major bones of the basicranium: the ethmoid, sphenoid, occipital, and 
temporal bones (Sperber, 1989; Kjaer, 1990; Williams et al., 1995). Sphenoid, occipital, and 
temporal bones have several contributions from intramembranous bones, whereas ethmoid is 
exclusively endochondral in origin (Sperber, 2001). 
 
 
 
Fig. 1. The cartilages of the chondrocranium (from M. T. Cobourne, A. T. DiBiase, 2010). 
 
Bony elevations divide the cranial base into anterior, middle, and posterior cranial fossae. The 
lesser wing of the sphenoid marks the division between anterior and middle cranial fossa and 
the petrous temporal sets the boundaries between middle and posterior cranial fossa. The 
anterior cranial fossa lies at a superior level compared to middle cranial fossa, which in turn is 
located more superiorly than the posterior cranial fossa (Premkumar, 2011; Fig. 2). 
  - 8 - 
Basicranial development is governed by three important principles. The centre of the 
basicranium completes growing faster than the anterior, posterior, and lateral portions; 
possibly because it is the region where important nerves and vessels penetrate the skull. 
Furthermore, the anterior and posterior cranial base grow to a certain extent independently; a 
phenomenon potentially attributed to the distinct embryologic origins of them. Finally, most 
basicranial growth in the three cranial fossae occurs independently (Sperber, 1989; Lieberman 
et al., 2000). 
 
Posterior 
Cranial 
Fossa
Middle 
Cranial 
Fossa
Anterior 
Cranial 
Fossa
Anterior Cranial Fossa
Middle Cranial Fossa
Posterior Cranial Fossa
 
 
Fig. 2. The cranial fossae, left: superior view, right: lateral view (adapted from F. H. Netter, 
2011).  
 
2.1.2. The growth of cranial base and its implications in the facial shape 
 
The growth of cranial base is a complex sequence of events and happens both within and 
between endocranial fossae. It is accomplished by primary displacement of bone due to 
expanding lobes of the brain, linear displacement caused by growth at synchondroses and 
extensive cortical remodelling (Stark, 1975; Premkumar, 2011). Growth occurs as angulation 
  - 9 - 
and in antero-posterior, medio-lateral, and supero-inferior dimensions. The cranial growth 
plate, which is located at the midline axis of the cranial base and includes the intersphenoidal, 
spheno-ethmoidal, and spheno-occipital synchondroses, contributes to overall growth of 
cranial base at the synchondroses via interstitial growth of a pressure-adapted mechanism of 
endochondral ossification (Enlow and Hans, 1996; Proffit et al., 2007; Fig. 3).  
 
Spheno-occipital 
synchondrosis
Spheno-ethmoidal 
synchondrosis
Intersphenoidal 
synchondrosis
 
 
Fig. 3. The synchondroses of the cranial base (adapted from 
http://www.anthropology.pitt.edu/node/957, last access on 09.01.2016). 
 
Antero-posterior growth is, except for displacement due to growth of functional matrix, 
attributed to the midline axis of the cranial base where all the synchondroses are located. 
Postnatally, the posterior cranial base mainly elongates through deposition in the spheno-
occipital synchondrosis, whereas anterior cranial base (measured from sella to foramen 
caecum) through deposition in the spheno-ethmoidal synchondrosis. Anterior cranial base 
attains approximately 95% of its adult length at approximately six years and spheno-
ethmoidal synchondrosis ceases contributing to antero-posterior growth after the age of seven 
years (Scott, 1958; Stark, 1975; Sperber, 2001). 
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Medio-lateral growth is not attributed to the cranial growth plate, instead it happens primarily 
through drift and intramembranous bone growth in sutures with regard to anterior and 
posterior cranial fossae and through lateral drift of the squamous portions of the sphenoid 
with regard to the middle cranial fossa. Furthermore, supero-inferior growth occurs through 
drift, thus also lacking a contribution of the cranial growth plate to growth (Sperber, 1989). 
Angulation of cranial base is a unique characteristic of humans and happens as an aftermath 
of bone or cartilage deposition in the midline axis of the cranial base that changes the angle 
between intersecting anterior and posterior cranial base. This causes the inferior cranial base 
angle to become more acute (flexion) or more obtuse (extension) (Lieberman et al., 2000). 
Cranial base angulation is a resultant of different growth processes at different locations of the 
cranial base. 
All the synchondroses of the cranial base play, among others, a role on angulation of the 
cranial base via interstitial growth (Bjork, 1955; Scott, 1958; Giles et al., 1981; Enlow, 1990). 
The prenatal involvement of them in flexion or extension lies on the decreased chondrogenic 
activity in the inferior vs. superior part of the synchondrosis causing flexion, whereas 
extension results from a decreased chondrogenic activity in the superior compared to inferior 
part of the synchondrosis (Hofer, 1960; Hofer and Spatz, 1963; Stark, 1975; Diewert, 1985 
Anagastopolou et al., 1988; Sperber, 1989). However, only the spheno-occipital 
synchondrosis seems to play an important role on cranial base angulation postnatally. It 
remains an active site until the age of 20 years, while spheno-ethmoidal fuses at six to eight 
years and intersphenoidal prior to birth (Bjork, 1955; Scott, 1958; Premkumar, 2011). 
The fact that cranial base is not flat causes the foramen magnum to have a relatively more 
anterior position and ventral orientation, which in turn reduces the lever arm between the 
centre of mass of the head and the atlanto-occipital joint, thereby the magnitude of the force 
required to hold up the head is reduced (Schultz, 1942). The flexure of human cranial base; it 
demonstrates an angulation of 65 ° at clivus, between the middle and posterior cranial fossa, 
contributes to the orthograde posture of man, redirection of the face from forward to 
downward direction, and anterior and inferior movement of the middle face (Premkumar, 
2011). 
According to Enlow’s (Enlow and Hans, 1996) counterpart principle of craniofacial growth, 
there are regional relationships throughout the whole face and cranium, which consist of 
anatomical parts that are directly related to their specific anatomical counterparts. If both parts 
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and their corresponding counterparts enlarge to the same extent, then balanced growth 
between them is the result. Imbalances are caused by differences in the amount or direction of 
growth between parts and their particular counterparts. The upper part of the nasomaxillary 
complex, the anterior cranial fossa, the palate, and the mandibular corpus are considered by 
Enlow (Enlow and Hans, 1996) to be the counterparts of bony maxillary arch, while the 
ramus of the mandible is the structural counterpart of the middle cranial fossa. 
Anterior cranial fossa comprises the orbital plates of frontal bone and crista galli. After eight 
years of age, its lengthening is directly due to growth of functional matrix (Premkumar, 
2011). The upper face shares same bony elements with the anterior cranial base resulting in a 
high degree of integration between these two regions. It seems that anterior cranial base 
affects the orientation of the upper face directly, but that it only not immediately affects palate 
orientation through the integration of palate and orbits (Lieberman et al., 2000). 
The middle cranial fossa and the ethmomaxillary complex, although they do not demonstrate 
as tight anatomical relationship as this of anterior cranial base and upper face, interact in a 
way that the shape of the former seems to influence not only the orientation of the posterior 
border of the later but also its location in relation to the rest of the cranial base (Hoyte, 1991). 
Expansion of the middle cranial fossa due to growth of temporal lobe has a secondary 
displacement effect on anterior cranial fossa, ethmomaxillary complex, and mandible. 
Because of the position of posterior border of maxillary complex at the intersection between 
the anterior and middle cranial fossae, the growth of middle cranial fossa displaces forward 
the anterior cranial fossa and the ethmomaxillary complex suspended beneath it (Enlow and 
Hans, 1996; Premkumar, 2011). The forward displacement of the mandible is less than this of 
anterior cranial fossa and ethmomaxillary complex because most of the growth of the middle 
cranial fossa occurs anterior to mandibular condyles. Additionally, according to Enlow’s 
(Enlow and Hans, 1996) counterpart principle of growth the ramus of the mandible elongates 
in a matched way to the elongation of the middle cranial fossa resulting in placing the 
mandibular arch in a more anterior position. 
Posterior cranial fossa through the inclination of clivus, where the spheno-occipital 
synchondrosis is located, is responsible for the anterior and forward growth of the cranial 
base. Among others, growth of spheno-occipital synchondrosis results in an anterior and 
inferior displacement through the lengthening of clivus, which orients the nasomaxillary 
complex downward and forward. In turn, the downward and forward orientation of 
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nasomaxillary complex affects the vertical dimensions of the middle and lower face 
(Premkumar, 2011). 
 
2.1.3. Angulation of cranial base and occlusal type 
 
Because of its position, cranial base is difficult to be directly measured. In orthodontics, 
cranial base is traditionally measured through lateral cephalometric radiographs. A commonly 
used measurement is the angle nasion-sella-basion. Nasion however is not a satisfactory point 
because of its position outside the limits of the cranial base and the change in its position with 
age (Scott, 1958). Alternatively, nasion can be replaced with the foramen caecum or the 
intersection of the orbital roof and the inner surface of the frontal bone (Lieberman and 
McCarthy, 1999). Posteriorly, basion is often replaced by articulare and Bolton points 
(Dhopatkar et al., 2002). 
There is an abundance of studies supporting the relationship between cranial base angulation 
and type of malocclusion. In studies comparing Class II and Class III not only with Class I but 
also with each other, a progressive increase was found in cranial base angulation from Class 
III, via Class I, to Class II individuals (Hopkin et al., 1968; Dibbets, 1996). Furthermore, 
studies comparing Class II with Class I individuals reported a larger cranial base angulation in 
Class II than Class I individuals (Anderson and Popovich, 1983; Bacon et al., 1992). This 
feature was found to be related with the prepubertal developmental stage (Kerr and Hirst, 
1987; Franchi et al., 2007). As far as Class III malocclusion is concerned, the basicranial 
angulation was reported more decreased in Class III sample compared with a mixed Class I 
and II control sample (Proff et al., 2008). Moreover, compared with Class I, Class III 
malocclusion showed a more prominent cranial base flexure (Mouakeh, 2001; Chang et al., 
2005). The alteration in basicranial angulation in Class III malocclusion was related with 
changes occurring in posterior leg of the cranial base (Chang et al., 2005; Proff et al., 2008), 
supporting the theory of deficient orthocephalization (Singh et al., 1997).  
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2.2. The process of endochondral ossification 
 
Endochondral ossification is a mechanism of bone formation defined by the presence of a pre-
existing hyaline cartilaginous model of the developing bone. Endochondral ossification is 
distinguished from intramembranous ossification because of the presence of a hyaline 
cartilaginous model and the simultaneous presence of cartilage and bone during the 
ossification process (Henrikson et al., 1997). 
 
2.2.1. Early differentiation of chondrocytes 
 
Chondrogenesis is the process of producing cartilage intermediate that induces endochondral 
ossification during skeletal development. It includes distinct stages and is initiated by the 
mesenchymal cell recruitment, migration, proliferation, and condensation. Commitment of 
mesenchymal cells is strongly dependent on their interactions with the overlying epithelium, 
which activates signalling pathways and transcription factors (Olsen et al., 2000). Before 
mesenchymal cells condensate, they produce extracellular matrix containing hyaluronan, 
collagen type I and IIA (Goldring et al., 2006). Collagen type IIA belongs to non-cartilage 
collagens, as it is expressed not only by chondroprogenitor cells but somites or epithelial cells 
as well (Sandell et al., 1994; Fig. 4). 
Precartilaginous condensations of chondroprogenitor cells are characterised by increased cell 
adhesion and formation of gap junctions, and changes in the cytoskeleton (Goldring et al., 
2006). An escalation in hyaluronidase activity together with the appearance of cell adhesion 
molecules, N-cadherin and neural cell adhesion molecule (N-CAM), are evident during this 
phase. Transforming growth factor (TGF-β), which is an early signal of condensation, triggers 
the production of fibronectin. The connection of Syndecan to fibronectin reduces N-CAM 
secretion, thus drawing the boundaries of the condensation (Goldring et al., 2006). 
The transition of chondroprogenitors to chondrocytes is commenced by intracellular 
signalling pathways such as fibroblast growth factors (FGFs), hedgehog , bone morphogenetic 
proteins (BMPs), and Wnt. Wnt signals are required to induce the production of FGFs, which 
act in positive feedback loops (Niswander, 2003). The homeodomain (Hox) transcription 
factors coordinate proliferation of cells within the condensations and they are required for the 
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FGF-8 and sonic hedgehog (Shh) expression (Goldring et al., 2006). BMPs are vital not only 
for the formation of precartilaginous condensations but also for the differentiation of 
chondroprogenitors into chondrocytes (Yoon and Lyons, 2004). 
 
 
 
Fig. 4. Early and terminal chondrogenic differentiation. Growth factors and signalling for 
each differentiation stage are presented on the left and biological markers on the right; MSCs: 
mesenchymal stem cells (from S. Grassel, N. Ahmed, 2007). 
 
During the differentiation of chondroprogenitors to chondrocytes, BMPs signalling induces 
the expression of Sox proteins (Yoon et al., 2005). The Sox9 transcription factor is co-
expressed with two additional Sox family members and is needed for the collagen II gene to 
be expressed along with other cartilage-specific matrix proteins (Ng et al., 1997; Lefebvre et 
al., 2001). BMPs not only induce the expression of various transcription factors but via 
activation of TGF-β activated kinase 1 (Tak1) can trigger the p38 and JNK cascades (Yoon 
and Lyons, 2004). The stimulation of chondrogenic cellular condensation is provoked by the 
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p38 pathway and followed by cartilage nodule formation (Nakamura et al., 1999). During this 
stage, chondrocytes produce collagens II, IX and XI, and aggrecan. 
Subsequently, the differentiated chondrocytes begin to proliferate and form the proliferating 
zones. Proliferative zones are characterized by the existence of pairs of chondrocytes in a 
single lacuna within the cartilage matrix (Mackie et al., 2011). Proliferative chondrocytes 
subsequently separate from each other by an escalation in their secretion activity that features 
the following late hypertrophic stage (Mackie et al., 2011). The structure of synchondroses is 
bipolar: a central layer of small cartilaginous cells, with proliferative zone, hypertrophic zone, 
and zone of endochondral ossification on either side (Premkumar, 2011; Fig. 5). 
 
 
Bone  marrow 
Trabecular bone 
Invading blood vessels 
Hypertrophic zone 
Proliferating zone 
Proliferating zone 
Hypertrophic zone 
Resting zone 
 
 
Fig. 5. The bipolar structure of the spheno-occipital synchondrosis of a rat stained with 
Movat's pentachrome staining, Magn. ×100 (from V. Koretsi et al., 2015). 
 
The systemic regulator growth hormone (GH) stimulates the secretion of insulin-like growth 
factor 1 (IGF1) and the GH/IGF1 axis plays a key  role on promoting chondrocyte 
proliferation (Nilsson et al., 2005; Pass et al., 2009). Locally, the binding of Wnt family 
proteins to their receptor can activate either the canonical Wnt signalling pathway or the non-
canonical one. The former involves the accumulation of β-catenin, a cytoplasmic protein that 
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functions in cell to cell adhesion by interacting with cadherins, whereas the latter the 
degradation of β-catenin. At this stage, Wnt signalling pathways stimulate chondrocyte 
proliferation (Akiyama et al., 2004; Andrade et al., 2007). 
Indian hedgehog (Ihh) is required for normal chondrocyte proliferation throughout the growth 
plate during both embryonic and postnatal growth and secreted by prehypertrophic 
chondrocytes, a transitional phenotype between proliferation and hypertrophy (St-Jacques et 
al., 1999; Koyama et al., 2007; Maeda et al., 2007). Additionally, Ihh represses the onset of 
hypertrophic differentiation by activation of parathyroid hormone-related peptide (PTHrP) 
expression, thus maintaining chondrocytes in the proliferative stage (Vortkamp et al., 1996). 
The Gli family of transcriptional factors plays an essential role on regulating responses of 
chondrocytes to Ihh (Wuelling and Vortkamp, 2010). These responses rely upon the unique 
contributions of primary cilia (Koyama et al., 2007). Ihh, through PTHrP, prevents premature 
differentiation into prehypertrophic and hypertrophic phenotypes and define the number of 
cells that will exit the proliferative phase and differentiate further accordingly proceeding to 
the endochondral ossification pathway (Kobayashi et al., 2005). 
FGFs acting through FGF receptor 3 (FGFR3), a tyrosine kinase receptor, serve as inhibitors 
of the proliferation of chondrocytes and stimulate factors of chondrocyte hypertrophy (Minina 
et al., 2002; Yoon et al., 2006). FGFR3 signalling can also restrain Ihh expression (Liu et al., 
2002). FGFs activity is modulated by glycosaminoglycans and desulphation of 
glycosaminoglycans appears to limit the FGFs-induced repression of chondrocyte 
proliferation (Ornitz, 2005; Chuang et al., 2010). Contrary, binding of BMPs to their receptors 
leads to stimulation of chondrocyte proliferation and inhibition of hypertrophic  
differentiation. BMPs also induce the secretion of Ihh and reversely Ihh induces the secretion 
of various BMPs, but their interaction is not in an absolute dependent manner (Minina et al., 
2001). The rate of proliferation is determined by the balance of signalling between BMPs and 
FGFs, which also conform the sequential transition to the hypertrophic phenotype with the 
proliferation rate (Minina et al., 2002). 
The cartilage matrix principally consists of aggrecan and hyaluronan arranged in the fibrillar 
network of collagen type II, which serves as the framework for the tissue. The collagenous 
network provides tensile strength, while the proteoglycans contribute to the elastic properties 
of the tissue (Gentili and Cancedda, 2009). Cartilage matrix also involves other types of 
collagen to a lesser extent and other non-collagenous matrix proteins. All the components of 
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the cartilage matrix build an intricate network of interacting molecules, thus regulating the 
behaviour of chondrocytes (Heinegard, 2009). Numerous factors, such as IGF1, BMPs or 
TGF-β, stimulate expression and secretion of the components of the extracellular matrix, yet 
the role of the transcription factor Sox9 is definitely critical (Ng et al., 1997; Lefebvre et al., 
2001; Yoon et al., 2005). 
 
2.2.2. Terminal differentiation of chondrocytes and endochondral ossification 
 
The process of endochondral ossification involves the terminal differentiation of chondrocytes 
to the hypertrophic phenotype, calcification of the cartilage matrix, vascular invasion, and 
finally ossification (Goldring et al., 2006; Fig. 4). In order to undergo hypertrophy, 
chondrocytes have to increase their cellular fluid volume by almost 20 times. They then stop 
dividing and they create hypertrophic zones, in which they are arranged in multicellular 
clusters, often forming a columnar structure (Mackie et al., 2011). Hypertrophic chondrocytes 
are present in two forms depending on their appearance: light and dark cells (Anderson, 1964; 
Ahmed et al., 2007). 
Hypertrophic chondrocytes begin to alter the cartilage matrix and this is abetted by a shift in 
their secretion activity. A specific biological marker of this stage include collagen type X, a 
non-fibrillar collagen type, and this is accompanied by the secretion of alkaline phosphatase 
(ALP), matrix metalloproteinases (MMPs), and vascular endothelial growth factors (VEGFs) 
(Colnot and Helms, 2001; Inada et al., 2004). MMPs degrade collagen type II, which is 
downregulated during hypertrophy (Ortega et al., 2004). VEGFs promote the vascular 
invasion, which is needed in order the cartilage to be replaced by bone (Colnot and Helms, 
2001; Colnot et al., 2004). 
The critical transition of chondrocytes to the hypertrophic phenotype is regulated by systemic 
factors, such as thyroid hormones, as well (Shao et al., 2006; Wang et al., 2007). The 
canonical Wnt signalling pathway (Enomoto-Iwamoto et al., 2002; Chen et al., 2008), IGF1 
(Wang et al., 2010) and FGFR3 (Minina et al., 2002; Ornitz, 2005) appear to be mediators of 
the triiodothyronine hormone (T3)-induced chondrocyte hypertrophy. Furthermore, thyroid 
hormones abolish expression of PTHrP and PTHrP-R, which could be another either direct or 
indirect way for facilitating chondrocyte hypertrophy (Stevens et al., 2000). 
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Runx2 is a key transcription factor inducing hypertrophy (Otto et al., 1997; Enomoto et al., 
2000; Komori, 2005). As mentioned above, PTHrP is activated by Ihh and inhibits 
hypertrophy of chondrocytes. PTHrP exerts its effects via suppression of expression of the 
Runx2 transcriptional factor (Lefebvre and Smits, 2005) and probably by Sox9, which is 
activated by PTHrP and indirectly reduces Runx2 expression (Huang et al., 2000). Although 
Ihh is considered to inhibit hypertrophy, it has been shown that in the absence of PTHrP, Ihh 
appears to promote chondrocyte hypertrophy (Mak et al., 2008). 
Late hypertrophic chondrocytes produce and release matrix vesicles that initiate mineral 
deposition in skeletal tissues. They can qualitatively adjust the production of matrix vesicles 
and release mineralization-competent matrix vesicles rich in annexin V and alkaline 
phosphatase only when they are stimulated to induce mineralization (Kirsch et al., 1997; 
Kirsch, 2006). PHOSPHO1 phosphatase and tissue non-specific alkaline phosphatase (TNAP) 
both play a role on the mineralisation of cartilage matrix. PHOSPHO1 initiates mineralisation 
within the matrix vesicle, while TNAP progresses the mineralisation outside the boundaries of 
the matrix vesicle (Fedde et al., 1999; Anderson et al., 2004; Yadav et al., 2011). 
The cartilage matrix remodelling and the angiogenesis induced by the activity of hypertrophic 
chondrocytes change the environmental stress experienced by hypertrophic chondrocytes, 
which eventually undergo physiological death (Goldring et al., 2006). Most hypertrophic 
chondrocytes seem to undergo rapid death before the ossification front (Mackie et al., 2011). 
Their rapid death is attributed to the apoptotic pathway, since features pertinent to apoptotic 
cell death were identified. Further, the apoptogenic activity of some peptides of extracellular 
matrix proteins was found to be powerful (Adams and Shapiro, 2002). Following apoptosis of 
chondrocytes, the transverse septa of the cartilage matrix enclosing them are broken down, 
prompting the invasion and differentiation of the cells that extend the ossification centre. 
Many of the vertical septa are maintained as a scaffold for bone matrix deposition (Mackie et 
al., 2011). 
Endochondral ossification starts from all the corners of the synchondrosis (Premkumar, 
2011). MMP13 and MMP9 work synergistically in a coordinated process to cleave the two 
major components of the cartilage matrix, collagen type II and aggrecan (Stickens et al., 
2004); with cleaving of collagens being of superior importance compared to cleaving of 
aggrecan in regard to the normal development of the growth plate (Little et al., 2005). 
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Vascular invasion takes place without preceding osteoclastic activity, since angiogenesis and 
osteoclastogenesis were found to be dissociated in vivo (Deckers et al., 2002). A specialized 
cell type called septoclast facilitates the invading capillaries by breaking down the terminal 
transverse septum and providing the invasive path (Gartland et al., 2009). Osteoclasts are 
responsible for cartilage matrix degradation promoting the invasion of bone marrow cells or 
the deposition of bone matrix by osteoblasts (Mackie et al., 2008). 
Factors produced by hypertrophic chondrocytes adjust the replacement of cartilage matrix by 
bone to the preparation of growth plate for invasion. By this means, hypertrophic 
chondrocytes regulate the  behaviour of the invading cells. The chemoattractant high-mobility 
group box 1 protein (HMGB1) produced by hypertrophic chondrocytes attracts endothelial 
cells, osteoclasts, and osteoblasts (Taniguchi et al., 2007). Moreover, the receptor activator of 
NFkB ligand (RANKL) is a factor also produced by hypertrophic chondrocytes and is 
required for osteoclast invasion and differentiation (Kishimoto et al., 2006). RANKL 
production by hypertrophic chondrocytes induces formation of osteoclasts through BMP2 and 
Runx2 and could therefore regulate resorption of calcified matrix by osteoclasts (Usui et al., 
2008). 
When the proliferative potential of chondrocytes at the growth plate is exhausted, growth 
plate closure is initiated. Oestrogen acts indirectly by accelerating the programmed 
senescence of the growth plate, thus exhausting the proliferative potential of chondrocytes. 
Ossification of the growth plate then occurs as an aftermath (Weise et al. 2001). 
 
2.3. The role of reactive oxygen species and antioxidants on endochondral ossification 
 
Reactive oxygen species (ROS) are derivatives of aerobic metabolism and exposure to various 
natural and synthetic toxicants. Failure of cellular mechanisms to cope with elevated ROS 
levels can cause oxidative stress, which can lead to various deleterious phenomena, such as 
apoptosis, inflammatory response or ischemia. The cellular armamentarium against such a 
challenge includes multiple layers of antioxidant defences (Davies, 2000; Fig. 6). 
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Fig. 6. Redox regulation from antioxidant enzymes (from R. J. Aitken, S. D. Roman, 2008). 
 
However, although ROS had been better studied in regard to their cytotoxic effects, their 
semantic involvement in eukaryotic signal transduction is well established nowadays 
(Sundaresan et al., 1995; Lander, 1997; Rhee, 1999; Rhee et al., 2000; Forman et al., 2004). 
ROS are generally thought to act as signalling molecules through the following sequence of 
events: (1) in response to various stimuli they can be generated on the surface of the cells or 
within intracellular compartments of them, (2) after their entrance into the cytoplasm, they 
can react with various proteins and modulate their function, (3) the changes in protein activity 
induced by ROS define specific cellular responses, and (4) once the stimulus disappears, ROS 
are degraded and the system returns to its original state (Hurd et al., 2012). 
Hydrogen peroxide (H2O2) can trigger various biological responses. Biological responses 
caused by H2O2 depend both on the cell type and the concentration of H2O2 within a cell 
(Chen et al., 2005; Choi et al., 2005; Sablina et al., 2005). In other words, in order the same 
biological response to be induced, different H2O2 levels are required among different types of 
cells, and distinct biological responses can be induced in response to low compared with high 
levels of H2O2 within a cell. Additionally, the detoxifying effect of antioxidant enzymes on 
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H2O2 seems to influence the biological response by controlling the local levels of H2O2 
(Chang et al., 2004). 
Thus, the role of antioxidant enzymes is of dual nature. It is not only restricted to the survival 
of cells by preventing cellular damage caused by increased H2O2 levels but it is also extended 
to the adjustment of biological response by regulating local H2O2 levels. In combination with 
the regulatory action of antioxidant enzymes, H2O2 can trigger various biological responses 
such as cell division, apoptosis, differentiation or migration (Sauer et al., 2000; Arnold et al., 
2001; Cai, 2005; Li et al., 2006; Ushio-Fukai, 2006). 
The involvement of ROS in regulation of cellular processes, which are vital during 
developmental stages, suggests that redox regulation is essential during development. Indeed, 
ROS have been implicated in several developmental processes such as spermatogenesis, 
oogenesis, and angiogenesis (Covarrubias et al., 2008). The effect of ROS on the process of 
endochondral ossification needs further elucidation; however, there is recent evidence 
supporting the crucial role of ROS during endochondral ossification. 
In particular, Fragonas et al. (1998) tested the impact of ROS both on resting and 
hypertrophic chondrocytes, the antioxidant activity of them and the ability of ROS to induce 
the production of alkaline phosphatase-enriched matrix vesicles by hypertrophic 
chondrocytes. The extent of cell damage due to ROS treatment was estimated from free LDH 
activity as percent of total LDH activity of the culture. ROS promoted the damage of 
approximately 25% of hypertrophic chondrocytes compared with approximately 46% damage 
of resting chondrocytes. Catalase activity was higher in hypertrophic than resting 
chondrocytes but superoxide dismutase (SOD) activity was less in hypertrophic compared 
with resting chondrocytes. The phospholipid hydroperoxide glutathione peroxidase (Gpx4) 
was identified at a higher level in resting rather than hypertrophic chondrocytes. Finally, the 
release of matrix vesicles by hypertrophic chondrocytes demonstrated a significant increase 
after the treatment of chondrocytes with ROS. 
Morita et al. (2007) investigated the levels of ROS in hypertrophic chondrocytes, the effect of 
ROS in chondrocyte differentiation process and the pathways activated by ROS during the 
process. It was revealed that hypertrophic chondrocytes demonstrate high levels of ROS. 
Furthermore, ROS initiated the inhibition of proliferating chondrocytes, while they stimulated 
the differentiation of proliferating to hypertrophic chondrocytes. The induction of 
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differentiation from proliferating to hypertrophic chondrocytes involved the activation of 
ERK and p38 MAPK pathways. 
Kim et al. (2010) studied the contribution of several NADPH oxidases (Nox) as ROS 
generating sources in chondrogenesis. It was found that Nox were essential for chondrocyte 
differentiation as contributing to the elevation of intracellular ROS levels. Nox1 and Nox2 
were increased during the time course of differentiation, whereas Nox4, although relative high 
initially, was decreased afterwards. The depletion of both Nox2 and Nox4, but not Nox1, 
resulted in a cessation of ROS generation and chondrocyte differentiation. Additionally, the 
depletion of Nox2 and Nox4 induced apoptosis and inhibited the accumulation of 
proteoglycans. 
 
2.4. Glutathione peroxidase 1 
 
Glutathione peroxidases (Gpxs) belong to the broad family of selenium- or cysteine-
containing proteins. Glutathione peroxidase 1 (Gpx1) was the first to be described in 1957, as 
an enzyme that protects hemoglobin of erythrocytes from oxidative breakdown (Mills, 1957). 
Later much more types of Gpxs were discovered not only in mammalian vertebrates, but in 
non-mammalian vertebrates as well. Under the general term “glutathione peroxidases” is 
considered to be a wide range of proteins that demonstrate sequence homology; such as Gpx1, 
Gpx2, Gpx3, Gpx4, and Gpx5. Although selenium-containing Gpxs were detected in non-
mammalian vertebrates as well, the vast majority of Gpxs are cysteine-dependent in the 
former form of life (Tosatto et al., 2008), whereas mammalian Gpxs contain selenocysteine,  
which is the main form of selenium metabolism in vivo (Sun et al., 2011). 
Gpx1 is a widely distributed intracellular protein; ubiquitously present in all tissues. It 
functions both in cytosol and mitochondria and its expression is higher in cytosol (70%) than 
in mitochondria (20-30%). It demonstrates a tetrameric structure with four identical subunits, 
each of which containing one atom of selenium (Se) bound as selenocysteine (Sec) moiety at 
the active site of the enzyme (Ursini and Maiorino, 2004; Rahman and Biswas, 2006). The 
Sec moiety is surrounded by the Gln, Asn, and Trp residues forming the catalytic tetrad that is 
conserved for Gpxs and normally located at the N-terminal end (Lu and Holmgren, 2009; 
Flohé and Brigelius-Flohé, 2012). 
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Sec is the redox-active moiety (peroxidatic Sec, UP) because in catalysis undergoes 
sequential conversions from reduced into oxidized form and then to a mixed selenodisulfide, 
and finally to the reduced form again (Rocher et al., 1992; Kulinsky and Kolesnichenko, 
2009). Oxidized and reduced substrates bind sequentially at the active site of Gpx1 in order 
the general reactions to occur: 2GSH + H2O2 → GSSG + 2H2O and 2GSH + ROOH → GSSG 
+ ROH + H2O (Kulinsky and Kolesnichenko, 2009; Fig. 7). 
 
 
 
Fig. 7. Reduction cycle of Gpx1 (adapted from W. Dröge, 2002). 
 
Specificity towards oxidized substrates for Gpx1 includes a wide range of organic 
hydroperoxides, such as H2O2, almost all aliphatic and cyclic organic peroxides (ROOH), 
polyunsaturated fatty acids, certain steroids, prostaglandin F2α (PGF2α), and prostaglandin 
G2 (PGG2) (Kulinsky and Kolesnichenko, 2009). Lipid hydroperoxides cannot be reduced 
from Gpx1 unless they are soluble; thus, they have to be pre-treated with phospholipase A2. 
This substrate specificity might be explained by the structure of the enzyme due to which the 
access of large substrates appears to be limited to the peroxidatic moiety at the active site 
(Toppo et al., 2009). On the other hand, Gpx1 demonstrates high specificity towards reduced 
substrates. Glutathione (GSH) is the only naturally occurring thiol that predominates in the 
cell and efficiently reduces Gpx1 (Kulinsky and Kolesnichenko, 2009; Toppo et al., 2009). 
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3. Materials and methods 
 
3.1. Materials 
 
The materials used in this study and their providers are listed in Tables 1-11 according to 
experimental procedure.  
 
Table 1. Consumables and their providers. 
Product Provider 
6-well culture plates Sarstedt AG & Co 
96-well qRT-PCR plates Biozym Scientific GmbH 
75-ml tissue culture flasks Sarstedt AG & Co 
Gloves Bio World Medical AG 
Cryotubes Carl Roth GmbH & Co KG 
Pasteur pipettes (5, 10, and 25 ml) (glass) VWR International 
Pasteur pipettes (5, 10, and 25 ml) (plastic) Sarstedt AG & Co 
Cell-culture dishes BD Falcon 
Forceps  Carl Roth GmbH & Co KG 
Pipettes „Eppendorf Research Plus“ 
0,1-2,5 μl 
Eppendorf AG, Hamburg 
Pipettes „Eppendorf Research Plus“ 
0,5-10 μl 
Eppendorf AG, Hamburg 
Pipettes „Eppendorf Research Plus“ 
2-20 μl 
Eppendorf AG, Hamburg 
  - 25 - 
Pipettes „Eppendorf Research Plus“ 
10-100 μl 
Eppendorf AG, Hamburg 
Pipettes „Eppendorf Research Plus“ 
100-1000 μl 
Eppendorf AG, Hamburg 
Electronic pipette „Easypet“  Eppendorf AG, Hamburg 
Pipet tips  Kisker Biotech GmbH & Co KG 
Reaction vessels (0.2, 0.5, 1, 1.5, and 2 ml)  Kisker Biotech GmbH & Co KG 
Reaction vessels (25 and 50 ml)  Sarstedt AG & Co 
Optical adhesive films „BZO Seal Film”  Biozym Scientific GmbH 
Scalpels Aesculap AG 
Centrifuge tubes (50 ml)  Sarstedt AG & Co 
Microscope slides Thermo Scientific 
Slide Staining System „EasyDip” Ted Pella, Inc. 
Cover slips 
Engelbrecht Medizin- und Labortechnik 
GmbH 
Syringe filters Sartorius 
 
Table 2. Laboratory equipment and corresponding manufacturers. 
Name Manufacturer 
Autoclave „SystecVX-150“  Systec GmbH 
CO2-Incubator  Binder 
Ice machine „ZBE 30-10“  ZIEGRA Eismaschinen GmbH 
Freezer  Robert Bosch GmbH 
Fridge „Liebherr CN 3556“  Liebherr 
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Microscope „Olympus IX 50“  Olympus Europa Holding GmbH 
Real-Time PCR cycler „Eppendorf Realplex“ Eppendorf AG, Hamburg 
Shaker Biometra 
Spectrophotometer 
„GENESYS 10S UV –VIS“ 
Thermo Scientific 
Laminar flow cabinet „Hera Safe KS“  Haereus Holding GmbH 
Liquid nitrogen storage tank (N2-tank)  Tec Lab GmbH 
Thermal cycler „Doppio 2.48 well“  VWR International 
Vortex „Genie 2“  Scientific Industries Inc. Bohemia NY. 
Analytical balance „KernABJ“  Kern & Sohn GmbH 
Water bath Köttermann 
Coulter counter Beckman Coulter 
Centrifuge „Eppendorf Centrifuge 5804 R“  Eppendorf AG, Hamburg 
Centrifuge „Haereus  Fresco  17 Centrifuge“ Haereus Holding GmbH 
Microtome HM 350 MICROM GmbH 
Paraffin water bath Medax Nagel GmbH 
Cooling plate KUNZ INSTRUMENTS AB 
Fume cupboard 
WALDNER Laboreinrichtungen GmbH & 
Co. KG 
Gel documentation system “GenoPlex” VWR International 
Gel electrophoresis system VWR International 
Semi-dry blotter  VWR International 
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Table 3. Materials for the cell culture. 
Product Provider 
ATDC5 cell line Sigma-Aldrich 
1:1 DMEM and Ham’s F-12 medium Sigma-Aldrich 
Fetal calf serum PAN-Biotech GmbH 
Antibiotics and antimycotics PAA Laboratories GmbH 
Human transferrin Sigma-Aldrich 
Sodium selenite Sigma-Aldrich 
Human insulin PromoCell GmbH 
Ascorbic acid Sigma-Aldrich 
Trypsin-EDTA Gibco 
PBS buffer Sigma-Aldrich 
Isotonic-II Carl Roth GmbH & Co KG 
 
Table 4. Materials for the RNA isolation. 
Product Provider 
peqGOLD TriFast reagent PEQLAB Biotechnologie GmbH 
Chloroform Merck Chemicals GmbH 
Isopropanol Merck Chemicals GmbH 
Ethanol Carl Roth GmbH & Co KG 
DEPC-water Carl Roth GmbH & Co KG 
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Table 5. Materials for the cDNA. 
Product Provider 
M-MLV Reverse 
Transcriptase, 50.000u 
M-MLV reverse transcriptase Promega 
Corporation M-MLV RT buffer, 5x 
 
Table 6. Materials for the qRT-PCR. 
Product Provider 
Primers 
Polr2a 
Eurofins MWG 
Operon 
Gpx1 
Col2a1 
Col10a1 
SYBR Green JumpStart Taq ReadyMix Sigma-Aldrich 
 
Table 7. Materials for the stains. 
Product Provider 
Acetic acid Merck Chemicals GmbH 
Alcian blue 8 GS Waldeck GmbH & Co KG 
Methanol Fisher Scientific 
Alizarin red S Carl Roth GmbH & Co KG 
 
Table 8. Materials for the immunohistochemistry. 
Product Provider 
Xylene Carl Roth GmbH & Co KG 
Ethanol Carl Roth GmbH & Co KG 
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Tris-EDTA buffer 
Tris  Sigma-Aldrich 
Hydrogen chloride Merck Chemicals GmbH 
EDTA AppliChem GmbH 
Tween 20 Carl Roth GmbH & Co KG 
DAKO peroxidase blocking reagent Dako 
Gpx1 primary antibody Abcam 
Secondary antibody Rockland Immunochemicals 
Diaminobenzidine chromogenic substrate Dako 
 
Table 9. Materials for the overexpression and knockdown of Gpx1. 
Product Provider 
Phusion high-fidelity 
PCR kit 
Phusion DNA 
polymerase 
New England Biolabs 
Deoxynucleotide 
solution 
Phusion HF buffer 
Phusion GC buffer 
MgCl2 solution 
Kontroll-Lambda 
template 
1.3 and 10 kb primers 
DMSO 
Quick-Load DNA 
marker 
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QIAquick gel 
extraction kit 
QIAquick spin 
columns 
Qiagen 
Buffer 
Collection tubes 
pcDNA 3.1 
Directional TOPO 
Expression Kit 
pcDNA 3.1D/V5-
His-TOPO 
Invitrogen 
dNTP mix 
Salt solution 
Sterile water 
T7 sequencing primer 
BGH reverse 
sequencing primer  
Control PCR 
template 
Control PCR primers 
Expression plasmid 
S.O.C. medium 
TOP10 cells 
pUC19 control DNA 
NucleoBond Xtra 
midi plus 
Buffer RES 
MACHEREY-NAGEL 
Buffer LYS 
Buffer NEU 
Buffer EQU 
Buffer WASH 
Buffer ELU 
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RNase A 
NucleoBond Xtra 
midi columns and 
column filters 
NucleoBond
 
finalizers 
30 ml syringes 
1 ml syringes 
Buffer TRIS 
LB medium Carl Roth GmbH & Co KG 
Serum-free medium Sigma-Aldrich 
TurboFect transfection reagent Thermo Scientific 
Trilencer-27 siRNA 
kit 
Gene-specific siRNA 
duplexes 
OriGene 
Universal scrambled 
negative control 
siRNA duplex 
Rnase free siRNA 
duplex re-suspension 
buffer 
 
Table 10. Materials for western blotting. 
Product Provider 
CelLytic M reagent Sigma-Aldrich 
Stacking and running 
SDS-gel 
Acrylamide mix Carl Roth GmbH & Co KG 
Tris Sigma-Aldrich 
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SDS  Carl Roth GmbH & Co KG 
APS Carl Roth GmbH & Co KG 
TEMED Carl Roth GmbH & Co KG 
Bromophenol blue Sigma-Aldrich 
SDS-running buffer 
Tris  Sigma-Aldrich 
SDS Carl Roth GmbH & Co KG 
Glycine Carl Roth GmbH & Co KG 
Transfer buffer 
Tris  Sigma-Aldrich 
Glycine Carl Roth GmbH & Co KG 
Methanol Fisher Scientific 
SDS  Carl Roth GmbH & Co KG 
TBS-T buffer 
Tris Sigma-Aldrich 
NaCl Carl Roth GmbH & Co KG 
HCl Fisher Scientific 
Tween 20 Carl Roth GmbH & Co KG 
Roti-Load 1, 4x Carl Roth GmbH & Co KG 
PVDF membrane Carl Roth GmbH & Co KG 
Filter papers GE Healthcare Europe GmbH 
Gpx1 primary antibody Abcam 
Secondary antibody Rockland Immunochemicals 
Powdered milk Carl Roth GmbH & Co KG 
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Table 11. Materials for the experiments on apoptosis. 
Product Provider 
Hydrogen peroxide Carl Roth GmbH & Co KG 
Annexin V-FITC 
apoptosis detection 
kit I 
Annexin V-FITC 
BD Pharmingen 
Propidium iodide 
staining solution 
Annexin V binding 
buffer 
 
3.2. Methods 
 
3.2.1. Culture conditions 
 
The mouse embryonal teratocarcinoma-derived ATDC5 cell line was used, which is a suitable 
in vitro model to simulate chondrogenic differentiation analogous to that occurring during 
endochondral ossification in vivo (Atsumi et al., 1990; Yao and Wang, 2013). Cells were 
thawed and seeded in 75ml-culture flasks. The medium consisted of 1:1 mixture of DMEM 
and Ham’s F-12 supplemented with 5% FCS (fetal calf serum) and 1% AA (antibiotics and 
antimycotics). Upon confluence observed with an optical microscope, cells were subcultured 
and the resulting passages were between 15th and 19th. The passaging of cells was done 
according to protocol in Table 12. 
Cells were inspected with light microscopy every day to confirm proper proliferation and 
absence of contamination. The protocol for determining the number of cells is presented in 
Table 13. 
The culture medium differed across experiments. To observe the temporal expression pattern 
of Gpx1 during chondrogenic differentiation, cells received the maintenance medium 
comprising 1:1 mixture of DMEM and Ham’s F-12 supplemented with: 
 5% FCS 
 1% AA 
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 10 μg/ml human transferrin 
 3 × 10
-8
 M sodium selenite 
 
Table 12. Protocol for passaging the cells. 
1 Removing the culture medium and washing cells with PBS buffer 
2 
Dissociating of cell contacts with 1, 0.2, and 0.4 ml trypsin for 75ml-culture flasks, 
6-well plates, and cell-culture dishes respectively 
3 Incubation for 4 min at 37 °C in a CO2 incubator 
4 
Addition of culture medium at least twice the amount of trypsin for inhibiting 
trypsin 
5 Transferring to tubes 
6 Sedimentation of cells by centrifugation at 1200 rpm for 5 min 
7 Removal of supernatants and resuspension of pellets in medium 
8 Determination of cell number with a Coulter counter 
 
Table 13. Protocol for determining the number of cells. 
1 Filling of 10 ml Isotonic-II in a plastic measuring vessel 
2 Adding 100 μl of the cell suspension and uniformly mixing by repeated shaking 
3 
Blank measurement with the Coulter counter according to the manufacturer's 
instructions (must be maximum 1% of the determined cell number / ml amount) 
4 Determination of cell number in the wells (cell number / ml) 
5 Calculating the required volume of cell suspension for the desired number cells 
6 Seeding and recultivation of the cells 
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For inducing chondrogenesis from the fifth day of culture (corresponding to day 0 of the 
measurements) and over the following 21 days, the differentiation medium was prepared by 
additionally supplementing the maintenance medium with (Altaf et al., 2006): 
 10 μg/ml human insulin  
 20 mg/ml ascorbic acid 
The aforementioned differentiation medium was also used for the knockdown experiments. 
For the overexpression experiments the medium was: 
 5% FCS 
 1% AA 
 10 μg/ml human transferrin 
 100 nM sodium selenite 
The medium was replaced every other day, unless otherwise stated, and cell cultures were 
maintained at 37 °C under a humidified atmosphere of 5% CO2. 
 
3.2.2. Isolation of RNA 
 
After washing cells with PBS buffer, 1 ml peqGOLD TriFast reagent was applied per well 
and left for 5 min. The solution was transferred to tubes, where 200 µl chloroform were 
added. The mixture was well vibrated and left until the separation of aqueous and organic 
phase. The mixture was then centrifuged at 4 °C and 14000 rpm for 10 min. The aqueous 
phase was removed to new tubes, where 400 μl isopropanol was pipetted. Samples were 
incubated at 4 °C for 10 min, followed by centrifugation at 4 °C and 14000 rpm for 15 min. 
Supernatants were removed and pellets were washed twice with 1 ml of 70% ethanol followed 
by centrifugation at 4 °C and 7500 g for 5 min. Pellets were left to dry for 10 min and RNA 
was dissolved in 25 μl DEPC-water. Samples were immediately placed on ice for subsequent 
quantification of RNA. 
A spectrophotometer was used for quantifying RNA at wavelengths of 260 nm and 280 nm. 
Whenever the concentration of nucleic acid in the samples was above 600 ng/μl, additional 
amount of DEPC-water was added. The purity of the samples was defined by the 
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OD260/OD280 ratio and samples were admissible whenever the ratio was above 1.8. After 
determining RNA concentration and purity, samples were stored at -80 °C until further 
handling. 
 
3.2.3. Reverse transcription 
 
RNA was transcribed to cDNA with the M-MLV Reverse Transcriptase. All the tubes were 
kept on ice throughout the process. Samples contained the following: 
 1 μg RNA template  
 4 μl M-MLV Reaction Buffer, 5x 
 1 μl Oligo(dT) 
 1 μl Random Hexamer 
 1 μl dNTP Mix, 10 mM 
 RNase-free H2O, summing up to a volume of 20 μl 
Samples were then incubated at 70 °C for 3 min. Afterwards, the  following were added: 
 1 μl RNase Inhibitor 
 1 μl M-MLV Reverse Transcriptase 
Samples were finally incubated at 37 °C for 60 min and at 95 °C for 2 min. They were then 
kept at -20 °C until further use. 
 
3.2.4. Quantitative Real-Time PCR 
 
Four primers were used for this study: polymerase II (Polr2a), glutathione peroxidase 1 
(Gpx1), Collagen type II (Col2a1), and collagen type X (Col10a1). The expression of Polr2a 
was set as the endogenous control, while Col2a1 and Col10a1 were chondrogenic gene 
markers corresponding to different stages of differentiation. Col2a1 is a well-established 
marker for the initial differentiation of chondrocytes, while Col10a1 is a marker for the 
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terminal differentiation (van der Earned et al., 2003; Mackie et al., 2008). Both of them have 
also been identified at the spheno-occipital synchondrosis (Römer et al., 2010). Primers are 
presented in Table 14. 
 
Table 14. Primers for the qRT-PCR used in this study. 
Name Symbol  Primer sequence 
Accession 
number 
Provider 
Polymerase 
(RNA) II (DNA 
directed) 
polypeptide A 
Polr2a 
F 5'-aatccgcatcatgaacagtg-3' 
NM_009089.2 
Eurofins 
MWG 
Operon R 5'-tcatccattttatccaccacct-3' 
Glutathione 
peroxidase 1 
Gpx1 
F 5'-tttcccgtgcaatcagttc-3' 
NM_008160 
Eurofins 
MWG 
Operon 
R 5'-tcggacgtacttgagggaat-3' 
Collagen, type 
II, alpha 1 
Col2a1 
F 5'-cggtcctacggtgtcagg-3' 
NM_031163.3 
Eurofins 
MWG 
Operon 
R 5'-ttatacctctgcccattctgc-3' 
Collagen, type 
X, alpha 1 
Col10a1 
F 5'-gcatctcccagcaccaga-3' 
NM_009925.4 
Eurofins 
MWG 
Operon 
R 5'-ccatgaaccagggtcaagaa-3' 
F: forward primer; R: reverse primer 
 
All the material was kept on ice throughout the process. All qRT-PCR reactions were 
performed in triplicates and for each pair of primers negative controls were included. The 
reaction mix consisted of the following: 
 5.25 μl DEPC-H2O 
 7.5 μl SYBR Green JumpStart Taq ReadyMix 
 0.375 μl forward primer (10 pmol/µl) 
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 0.375 μl reverse primer (10 pmol/µl) 
 1.5 μl cDNA (10x diluted) 
The reaction mix was pipetted in 96-well plates, which were covered with an optical adhesive 
film. Cycling conditions were as follows: 
 Heat up and initial denaturation at 95 °C for 5 min 
 Denaturation of the double stranded DNA at 95 °C for 10 sec 
 Annealing of primers at 60 °C for 8 sec 
 Elongation and fluorescence-point measurement at 72 °C for 8 sec 
The amplification reaction was repeated for 45 cycles and an extra step of melting curve was 
always included, to insure the specificity of primers. The melting curve step consisted of the 
following: 
 Initial denaturation at 95 °C for 15 sec 
 Annealing of primers at 60 °C for 15 sec 
 Rise of the temperature from 60 °C to 95 °C within 20 min with ongoing measurement of 
the fluorescence 
 Maintenance of the temperature at 95 °C for 15 sec 
In order to be statistically analysed, data were normalized against the endogenous control 
according to the formula: 
ΔCt = Ct endogenous control - Ct gene of interest 
For this purpose, the mean of the triplicates was always considered, if the standard deviation 
did not exceed 0.60. Otherwise, the outlier was excluded and the mean of the two remaining 
identical wells was taken into account. For presenting the data, the mRNA levels were 
normalized against the endogenous control and logarithmic scaled on the base of 2. They are 
presented as individual data points (Schmittgen and Livak, 2008): 2
ΔCt
. 
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3.2.5. Stains 
 
For visualizing the process of chondrogenic differentiation, Alcian blue and Alizarin red 
stains were used. Alcian blue stain reveals the formation of glycosaminoglycans in cartilage 
nodules (Shukunami et al., 1996). Cells were rinsed with 1 ml PBS buffer per well. They were 
then fixed with 1 ml of 0.1% glutaraldehyde and PBS buffer solution per well at room 
temperature for 20 min. Thereafter, cells were washed twice with Millipore water and left 
with 1 ml Alcian blue stain solution at room temperature for 30 min. Alcian blue stain 
solution consisted of 0.0125 g Alcian blue 8 GS, 0.375 ml of 10% acetic acid (pH = 2.5), and 
0.875 ml distilled water per well. After that, cells were rinsed under warm running tap water 
for 2 min. Finally, cells were washed with 1 ml Millipore water and inspected 
microscopically. 
Alizarin red stain shows the mineralization of the extracellular matrix (Shukunami et al., 
1997). Cells were washed with 1 ml PBS buffer per well and then fixed with 500 μl methanol 
at room temperature for 10 min. Subsequently, cells were washed with 1 ml distilled water 
per well and 500 μl Alizarin red S were applied and left at room temperature for 2 min. After 
removing Alizarin red S, cells were rinsed three times with 1 ml tap water and inspected 
microscopically. Photos for both stains were taken with an optical microscope. 
 
3.2.6. Immunohistochemistry 
 
The spheno-occipital synchondrosis from eight 10-days old male Wistar rats (Fig. 5, 8) was 
isolated and the corresponding paraffin-embedded tissue blocks were provided by Dr. Jens 
Weingärtner (Institute of Anatomy and Cell Biology, Ernst Moritz Arndt University of 
Greifswald). The paraffin-embedded tissue blocks were sectioned at 2 µm thickness with a 
microtome and sections were floated in a water bath. After transferring sections onto glass 
slides, they were left to dry overnight. 
On the day of use, samples were deparaffinized by incubating at 70 °C and immersing in 
xylene for 3 min. Then, tissues were hydrated in 95%, 70%, and 50% ethanol for 5, 5, and 10 
min respectively. To unmask the antigenic epitope, Tris-EDTA buffer (10 mM Tris, 1 mM 
EDTA, 0.05% Tween 20, pH 9.0) antigen retrieval was performed at 95 °C in a pre-heated 
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water bath for 2 h. Blocking of non-specific binding sites was done with DAKO Peroxidase 
Blocking Reagent for 10 min at room temperature. 100 µl anti-Gpx1 primary monoclonal 
antibody (1:250; ab108427, Abcam) were then applied for 1 h followed by 100 µl goat anti-
rabbit antibody conjugated with horseradish peroxidase (611-1302, Rockland 
Immunochemicals) for 30 min. Diaminobenzidine chromogenic substrate for antibody 
detection was applied for 3 min and samples were additionally counterstained in hematoxylin 
for 2 min. Tissue slides were dehydrated in ethanol and cleared in xylene before 
coverslipping. Negative controls included sections that were incubated without the primary or 
secondary antibodies. 
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Fig. 8. Cranial base of 10 days old Wistar rat dissected for immunohistochemistry, Magn. ×10 
(from V. Koretsi et al., 2015). 
 
Photographs of the immunostained sections were analysed at ×200 magnification factor. 
Immunoreactivity of Gpx1 was semiquantitatively determined by two independent observers 
and the agreement was assessed according to Landis and Koch (1977). The following grades 
were assigned to resting, proliferating, and hypertrophic zones: 
 
 
  - 41 - 
 Grade 0, no immunoreactivity 
 Grade 1, weak immunoreactivity (less than 25% of the cells) 
 Grade 2, moderate immunoreactivity (25-50% of the cells) 
 Grade 3, strong immunoreactivity (50-75% of the cells) 
 Grade 4, very strong immunoreactivity (more than 75% of the cells) 
 
Multiple sections were analysed per specimen and the median of replicates was then 
considered. Repeatability was assessed by analysing randomly selected photographs with an 
interval of a week. 
 
3.2.7. Overexpression and silencing of Gpx1 
 
The expression of Gpx1 was transiently manipulated in ATDC5 chondrogenic cell line. For 
the overexpression experiments, Gpx1 was amplified from the cDNA of ATDC5 cells with 
the Phusion High-Fidelity PCR Kit. The reaction mixture comprised 4 µl 5xPCR-buffer, 0.4 
µl dNTPs, 1 µl of 1:10 diluted cDNA containing 1 µg RNA, 1 µl of each primer, 0.2 µl DNA 
polymerase, and 12.4 µl H2O. The forward and reverse primers were 5'-
caccatgtgtgctgctcggctct-3' and 5'-ccttaggagttgccagactgc-3' respectively. Cycling conditions 
were 98 °C for 30 sec, followed by 30 cycles at 98 °C for 10 sec, 60 °C for 30 sec and 72 °C 
for 30 sec, and a final extension of 72 °C for 5 min. Extraction and purification of the 
amplificates was done with QIAquick Gel Extraction Kit. Specifically, 3 volumes of QG 
buffer were mixed with 1 volume of samples and the samples were then centrifuged with the 
QIAquick Spin Column for 60 sec. The flow-through was discarded and samples were 
washed with 0.75 ml PE buffer. Samples were again centrifuged for 1 min at maximum speed. 
The QIAquick Spin Column was placed into a clean microcentrifuge tube. Finally, 30 µl 
elution buffer were added, samples were left for 1 min, and they were then centrifuged for 1 
min. DNA was sequenced with Eurofins MWG Operon and the cloned sequence was found to 
be identical to the murine Gpx1 (NM_008160). 
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The mammalian expression vectors pcDNA 3.1D/V5-His-TOPO were transformed in 
Escherichia coli and the plasmid DNA was purified with NucleoBond Xtra Midi Plus. The 
culture stemming from diluting the starter culture 1: 1000 into LB medium was left to grow 
overnight. After harvesting bacterial cells, they were pelleted by centrifugation and the 
supernatant was discarded. Cells were resuspended in Resuspension Buffer RES + RNase A 
and the LYS buffer was added to the suspension at room temperature for 5 min. Then the 
EQU buffer was applied to the NucleoBond Xtra Column followed by NEU buffer for 
neutralization. After applying the lysate, the column filter and column were washed with 
EQU buffer and the column filter was discarded. The column was washed with WASH buffer 
and the plasmid DNA was eluted with ELU buffer. Subsequently, isopropanol for 
precipitating the eluted plasmid DNA was added and the samples were centrifuged. The 
supernatant was discarded and 70%  ethanol was added to the DNA pellet. After centrifuging, 
ethanol was removed and the pellet was left to dry. To reconstitute DNA, pellet was dissolved 
in Tris-EDTA buffer. Nucleic acid concentration and purity were determined by 
spectrophotometry. 
ATDC5 cells were transfected with Gpx1 or LacZ (control) plasmids in TurboFect 
Transfection Reagent. Twenty four hours prior to transfection, 5 × 10
5
 cells were seeded with 
4 ml medium in cell-culture dishes. 8 µg of DNA were diluted in 800 μl of serum-free 
DMEM medium per cell-culture dish and 12 μl of TurboFect were added to the diluted DNA 
per cell-culture dish. The mixture was incubated at room temperature for 20 min and then 800 
μl of it were added to each cell-culture dish dropwise. Finally, cell-culture dishes were gently 
rocked and incubated at 37 °C in a CO2 incubator for the next 72 h. The overexpression of 
Gpx1 in ATDC5 cells was confirmed with qRT-PCR. 
To knockdown Gpx1, siRNA transfections were performed with Trilencer-27 siRNA kit. 5 × 
10
5
 ATDC5 cells were seeded with 4 ml medium in cell-culture dishes 24 h prior to 
transfection and transfected with 5 nM Gpx1-siRNA and scrambled RNA as negative control 
(SR405153, OriGene). The siRNA was diluted to 5 μM using the sterilized duplex buffer 
supplied with the kit. Then, 5 μl of the diluted 5 μM siRNA were mixed with 320 μl serum-
free medium in tubes. 20 μl siTran were diluted with 240 μl serum-free medium and the 
dilution was added to the aforementioned siRNA solution. The mixture was incubated at room 
temperature for 10 min. The mixture was finally transferred to the cell-culture dishes and 
those were incubated at 37 °C in a CO2 incubator for the next 72 h. Knockdown of Gpx1 was 
confirmed with qRT-PCR. 
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3.2.8. Western blotting 
 
Western blot was performed to ensure protein expression after manipulating Gpx1 levels in 
ATDC5 cells. Cells were trypsinized and counted as previously described. They were 
subsequently centrifuged at 4 °C and 14000 rpm for 10 min. Supernatants were removed and 
pellets were resuspended in CelLytic M reagent (125 μl / 106 cells). They were then incubated 
on a shaker at room temperature for 15 min. After transferring the samples into 1ml-tubes, 
they were centrifuged  at 4 °C and 16000 rpm for 15 min. The protein-containing supernatants 
were transferred to new chilled tubes and samples were stored at -70 °C until further handling. 
The stacking and 15% running SDS-gel were prepared according to Table 15. The solution of 
the running SDS-gel was inserted into electrophoresis chamber. After its polymerization, the 
stacking gel was applied onto it along with the combs to form the slots. During 
polymerization of the stacking gel, samples were heated at 99 °C for 5 min to denature the 
proteins. 
 
Table 15. Composition of stacking and 15% running SDS-gel. 
Ingredients stacking gel 15% running SDS-gel 
H2O 1.4 ml 1.1 ml 
Acrylamide mix (30%) 330 μl 2.5 ml 
Tris  250 μl (1 M; pH 6.8) 1.3 ml (1.5 M; pH 8.8) 
SDS (10%) 20 μl 50  μl 
APS (10%) 20 μl 50 μl 
TEMED 2 μl 2 μl 
Bromophenol blue (0.5%) 0.6 μl - 
Total volume 2.0226 ml 5.002 ml 
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The solution containing 6 μg protein in 16 μl H2O and 4 μl Roti-Load 1, 4x was pipetted into 
the slots and the electrophoresis chamber was filled with SDS-running buffer, 1x (Table 16). 
A voltage of 80 V for 30 min was initially applied to the chamber and then the voltage was 
increased at 120 V for 90 minutes for separating the proteins. 
 
Table 16. Composition of SDS-running buffer, 1x. 
Ingredients Amount for SDS-running buffer, 10x 
Tris (pH 8.5) 30 g 
SDS 10 g 
Glycine 144 g 
Dissolving in distilled H2O and topping up to 1000 ml distilled H2O 
SDS-running buffer, 1x: 100 ml SDS-running buffer, 10x + 900 ml distilled H2O 
 
Methanol was subsequently applied to the polyvinylidene difluoride membrane (PVDF 
membrane) for 30 sec and the running SDS-gel was placed onto the PVDF membrane. Both 
of them were placed between several layers of filter paper saturated with transfer buffer, 1x. 
Care was taken to avoid air bubbles. The composition of  the transfer buffer, 1x is presented 
in Table 17. 
The stack was then placed onto a semi-dry blotter in direct contact with electrodes and the 
transfer of proteins to the PVDF membrane took place with 80 mA for 60 min. Before 
applying antibodies, blocking of non-specific binding sites was done with a solution 
containing 5% milk and 95% TBS-T, 1x prepared as presented in Table 18. The membrane 
was then incubated overnight at 4 °C on a shaker. 
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Table 17. Composition of the transfer buffer, 1x. 
Ingredients  Amount for transfer buffer, 1x 
Tris  58 g 
Glycine 29 g 
SDS (10%) 4 g 
Dissolving in distilled H2O and topping up to 1000 ml distilled H2O, resulting in transfer 
buffer, 10x 
Transfer buffer, 10x 100 ml 
Methanol 200 ml 
Topping up to 1000 ml distilled H2O, resulting in transfer buffer, 1x 
 
Table 18. Composition of TBS-T, 1x. 
Ingredients Amount for TBS-T, 10x 
Tris  24.23 g 
NaCl 80.06 g 
distilled H2O  800 ml 
Setting the pH to 7.5 with HCl (approximately 150 ml) 
Topping up to 1000 ml distilled H2O 
For TBS-T, 1x: 100 ml TBS-T, 10x + 899 ml distilled H2O + 1 ml Tween 20 
 
The Gpx1 primary antibody (1:2000, ab108427, Abcam) was applied in a solution of 0.5% 
milk and 99.5% TBS-T and incubated at room temperature for 90 min on a shaker. The 
membrane was then washed three times with TBS-T, each time for 10 min at room 
temperature on a shaker. Secondary antibody (1:5000, 611-1302, Rockland 
Immunochemicals) dissolved in the same solution was applied and incubated at room 
temperature for 60 min. The membrane was finally washed twice with TBS-T for 10 min, 
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once with PBS buffer for 5 min, and once with TBS-T for 5 min. The detection through 
chemiluminescence was carried out with the gel documentation system “GenoPlex” and its 
corresponding software “GenoSoft”. 
 
3.2.9. Exposure to H2O2 and apoptosis assay 
 
After incubating for 72 h, transfected cells were treated with exogenous H2O2 and the quantity 
of apoptotic cells was determined. After removing the old medium, ATDC5 cells were 
provided with 4 ml of fresh medium additionally supplemented with 250 µM H2O2. Cells 
were incubated at 37 °C in a CO2 incubator for 6 h, after which the percentage of cells 
undergoing apoptosis was assessed by flow cytometry with the Annexin V-FITC Apoptosis 
Detection Kit I. The medium was collected and centrifuged resulting in the formation of 
pellets, while adherent cells were trypsinized. Both resulting pellets were then united and 
quantified. For the staining, cells were initially washed twice with cold PBS buffer and then 
resuspended in binding buffer, 1x. 100 µl of the solution were transferred to tubes, where 5 µl 
FITC Annexin V and 5 µl PI (propidium iodide) were added. Tubes were gently vortexed and 
incubated at room temperature in the dark for 15 min. Finally, 400 µl of binding buffer, 1x 
were supplied to each tube and samples were analysed with a flow cytometer within an hour. 
The settings were the following: FSC = 5 V, SSC = 350 V, FITC = 335 V, and PerCP-Cy5-5 
= 395 V. 
 
3.2.10. Statistical analysis 
 
Statistical evaluation was performed using the SPSS programme, version 20.0 for Windows 
(SPSS Inc., Chicago, USA). All the statistical tests were two-sided at a level of significance 
p ≤ 0.05. Data on the temporal expression pattern and immunohistochemical quantification of 
Gpx1 were compared for significance with the Friedman’s two-way analysis of variance by 
ranks. If there was a total significance level of p ≤ 0.05, paired multiple comparisons were 
undertaken with the Wilcoxon test at an adjusted p value according to the correction of 
Bonferroni. Data on apoptosis were analysed with Welch’s ANOVA and multiple 
comparisons were undertaken with the Games-Howell test. Descriptive statistics are presented 
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as mean and standard error for continuous data, whereas median and interquartile range are 
given for ordinal data. 
For the statistical analysis of the apoptosis assay, each experimental sample was calculated 
relative to its control and expressed as a ratio. Specifically, the value of each control sample 
was equated to 1 and the value of the corresponding experimental sample was converted 
accordingly. 
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4. Results 
 
4.1. Chondrogenic differentiation of ATDC5 cell line 
 
4.1.1. Stains 
 
The chondrogenic differentiation of ATDC5 cells was determined with the stains Alcian blue 
and Alizarin red. The production of glycosaminoglycans (Fig. 9) and the calcification of 
extracellular matrix (Fig. 10) became intense with the course of differentiation. Furthermore, 
the formation of cartilage nodules is visible. 
 
 Day 2 Day 6 
Day 14 Day 10 
Day 0 
Day 21 
 
 
Fig. 9. Alcian blue stain for the visualization of glycosaminoglycans, Magn. ×40. 
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 Day 0 Day 2 Day 6 
Day 10 Day 14 Day 21 
 
 
Fig. 10. Alizarin red stain for the visualization of the calcified extracellular matrix,  
Magn. ×40. 
 
4.1.2. Expression of biological markers of chondrogenic differentiation 
 
There was a statistical significant difference in the expression of Col2a1 during differentiation 
in vitro (p = 0.003). The expression of Col2a1 increased significantly on days 10 (p = 0.02) 
and 14 (p = 0.03; Fig. 11). The expression of Col10a1 also differed across the different days 
of measurements (p < 0.0001). Although not detectable at the beginning of differentiation, the 
expression of Col10a1 moderately increased on days 6 and 10, and became statistically 
significantly increased on days 14 (p = 0.03) and 21 (p < 0.001; Fig. 12). 
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Fig. 11. Expression of Col2a1 early chondrogenic marker. 
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Fig. 12. Expression of Col10a1 late chondrogenic marker. 
 
4.2. Expression pattern of Gpx1 in vitro 
 
For Gpx1 investigated on the predetermined days, there was a statistically significant 
difference in its levels of expression during the 21 days (N = 6, χ2(6) = 20.43, p < 0.01). 
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Multiple comparisons identified a statistically significant increase relative to the endogenous 
control between the days 0 (18.3 ± 0.9) and 14 (117.6 ±  17.6, p = 0.03), 2 (17.6 ± 2.1) and 10 
(78.2 ± 4.7, p = 0.02), and 2 (17.6 ± 2.1) and 14 (117.6 ± 17.6, p = 0.01; Fig. 13). 
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Fig. 13. Expression of Gpx1 during chondrogenic differentiation in vitro (from V. Koretsi et 
al., 2015). 
 
4.3. Localization of Gpx1 expression at the spheno-occipital synchondrosis 
 
The Cohen's Kappa for the inter-observer agreement was 0.797 (p < 0.0001), which indicates 
a substantial agreement. The Wilcoxon signed-rank test for repeatability between the time 
points of evaluation was not significant (Z = -0.577, p = 0.56). The immunoreactivity of Gpx1 
was found to be statistically significantly different at the resting, proliferating, and 
hypertrophic zones of the spheno-occipital synchondrosis (χ2(2) = 15.200, p < 0.0001; Fig. 
14). The highest immunoreactivity was detected at the proliferating zones (4 ± 1), followed by 
the resting zone (3 ± 0.75). The hypertrophic zones demonstrated the lowest Gpx1 
immunoreactivity (1.5 ± 1), which was statistical significant in comparison to the resting (N = 
8, Z = -2.64, p = 0.02) and proliferating zones (N = 8, Z = -2.59, p = 0.02; Fig. 15). 
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Fig. 14. Gpx1 immunoreactivity at the spheno-occipital synchondrosis of the rat, left: 
negative control, Magn. ×200 (adapted from V. Koretsi et al., 2015).  
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Fig. 15. Semiquantification of Gpx1 immunoreactivity at the spheno-occipital synchondrosis 
of the rat (adapted from V. Koretsi et al., 2015). 
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4.4. Apoptosis assay after exogenous exposure to H2O2 
 
Results of the qRT-PCR for ensuring the manipulation of the Gpx1 expression are presented 
in Fig. 16. Furthermore, the expression of Gpx1 at the translational level was ensured with 
Western blot (Fig. 17). There was a statistically significant difference among groups as 
determined by Welch ANOVA (F(2, 9.25) = 3718.6, p < 0.001). The Games-Howell test 
showed that the apoptotic percentage of Gpx1-depleted chondrocytes was statistically 
significantly greater (66.1 ± 0.57%) compared to the control (17.7 ± 0.27%, p < 0.001) and 
cells overexpressing Gpx1 (10.9 ± 0.22%, p < 0.001). Furthermore, chondrocytes 
overexpressing Gpx1 had lower apoptotic rate (10.9 ± 0.22%) compared to control cells (17.7 
± 0.27%, p < 0.001; Fig. 18). 
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Fig. 16. Manipulation of Gpx1 expression measured with qRT-PCR. Gpx1-siRNA: Gpx1-
depleted cells; Gpx1-pcDNA3.1: Gpx1-overexpressing cells (adapted from V. Koretsi et al., 
2015). 
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Fig. 17. Manipulation of Gpx1 expression measured with Western blot. Reference using as 
loading control β-actin (above) and ATDC5 cells under depletion or overexpression of Gpx1 
(below). Gpx1-siRNA: Gpx1-depleted cells; Gpx1-pcDNA3.1: Gpx1-overexpressing cells.  
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Fig. 18. Apoptotic cells after exposure to H2O2. Gpx1-siRNA: Gpx1-depleted cells; Gpx1-
pcDNA3.1: Gpx1-overexpressing cells; Q1: dead cells; Q2: apoptotic cells; Q3: live cells; 
Q4: early apoptotic cells (adapted from V. Koretsi et al., 2015). 
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5. Discussion 
 
Chondrogenesis represents the initial step of endochondral bone formation, the developmental 
mechanism of the synchondroses of the cranial base. Development and growth of the cranial 
base strongly influence facial shape (Cendekiawan et al., 2010) and are thus of interest in 
orthodontics. One of the most common antioxidant enzymes, Gpx1, has not been investigated 
in relation to chondrogenesis so far. Due to their function on reducing oxidative levels, 
antioxidant enzymes are generally presented as means to avoid oxidative damage in  
numerous pathological processes (Baynes, 1991; Kumar et al., 2008). However, oxidative 
stress, except for numerous pathological processes, also rises during developmental 
procedures (Thomas et al., 1997; El Mouatassim et al., 1999). From this point of view, 
antioxidants could play an equally relevant role on development because of their capability 
for neutralizing ROS. 
In this study (Koretsi et al., 2015), the expression of Gpx1 gene was first monitored with 
qRT-PCR during chondrogenic differentiation in vitro, in an initial effort to observe and 
define its temporal expression pattern in chondrogenesis in vitro. It was observed that the 
expression of Gpx1 fluctuated during chondrogenic differentiation in vitro. On account of 
this, the next aim was to identify the extent of Gpx1 generation according to the 
differentiation stage of chondrocytes. For this purpose, Gpx1 was identified and localized 
through immunohistochemistry at the spheno-occipital synchondrosis of the cranial growth 
plate in rats. After discovering the different volumes of Gpx1-generation according to 
different stages of chondrogenic differentiation, the final objective was to determine the 
participation of Gpx1 in ROS scavenging as well as its impact on apoptosis in chondrocytes. 
The role of Gpx1 on ROS scavenging was flow cytometrically tested with an apoptotic assay 
in chondrogenic cells, whose Gpx1 levels were manipulated either with overexpression or 
knockdown in vitro. 
 
5.1. Expression of Gpx1 during chondrogenic differentiation 
 
The ATDC5 cell line used in this study is a well-accepted model for studying chondrogenic 
differentiation in vitro. In their review, Yao and Wang (2013) identified over 200 studies 
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utilizing the ATDC5 cell line to investigate bone formation. According to Altaf et al. (2006), 
the addition of vitamin C in the culture medium advances the differentiation of ATDC5 cells. 
In particular, an increase in biological markers of hypertrophic differentiation was observed 
within 7-10 days of administration of differentiation medium in experimental as compared to 
the control cultures. Therefore, it was concluded that hypertrophy occurs faster in ATDC5 
cells growing in media additionally supplemented with vitamin C. In fact, that was not 
surprising, since vitamin C is widely recognised as a promoter of differentiation in other types 
of cells as well (Franceschi et al., 1994; Takahashi et al., 2003). Hence, it was decided to 
include vitamin C to medium composition in order to avoid a shift in medium and CO2 
concentration previously needed for inducing differentiation in ATDC5 cells (Shukunami et 
al., 1997).  
The proposed mechanism of promoting differentiation through the addition of vitamin C in 
the medium is the formation of collagenous matrix, which in turn activates the ERK 
signalling pathway needed for differentiation (Temu et al., 2010). Except for vitamin C, the 
composition of the medium was as previously described (Shukunami et al., 1997). The 
differentiation of ATDC5 cells was verified with stains and expression of biological markers 
in this study. The colour intensity of the stains revealing proteoglycans and calcium in the 
matrix was increased during differentiation, while signs of cell aggregation were detected 
from day 10. On day 21, large cell condensations (cartilage nodules) were visible. These 
characteristics are consistent with cells undergoing chondrogenic differentiation (Shukunami 
et al., 1996; Shukunami et al., 1997). An emphasis must be put on the simultaneous increase 
in colour intensity for both stains, indicating that in vitro culture systems are difficult to be 
synchronised at the same differentiation stage (Pruszak et al., 2007). This practically means 
that proliferating and hypertrophic chondrocytes coexist in the same culture. 
The aforementioned characteristic of the in vitro culture systems has an influence on the 
expression of chondrogenic biological markers too. The expression of Col2a1 reached a peak 
on day 14, while Col10a1 on day 21. These findings are similar to those of Altaf et al. (2006), 
who utilised the same medium. However, the expression of Col10a1 was hardly detectable at 
the beginning and became visible from day 6 onwards, possibly indicating that hypertrophy in 
some cells began from that timepoint. 
Hence, it could be assumed that the increase in Gpx1 expression between the days 6 and 14 
coincided the hypertrophic status of some cells in the culture. However, this could serve only 
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as an estimate and not as a conclusion. On the contrary, the reliably drawn conclusion is that 
Gpx1 expression is not of constitutive nature during chondrogenic differentiation. 
 
5.2. Hypertrophic chondrocytes have the lowest Gpx1-immunoreactivity 
 
As opposed to the aforementioned limitation of in vitro conditions, ex vivo experiments can 
provide with a more realistic point of view. Therefore, the expression of Gpx1 was identified 
and localized at the spheno-occipital synchondrosis of rats. The potentiality of localizing the 
expression of Gpx1 at a specific differentiation stage increases with immunohistochemistry 
because the clearly distinct arrangement of chondrocytes in regard to their differentiation 
stage is preserved in the samples under investigation. 
Moreover, the frequently occurring variation in cellular transcriptome and proteome must be 
considered as a potential threat to the interpretation of gene expression data. Post-
transcriptional processing, mRNA degradation, and post-translational regulation strongly 
affect the cellular concentrations of proteins. The squared Pearson correlation coefficient 
between protein levels and their corresponding mRNA abundances amounted approximately 
0.40 for both bacteria and eukaryotes. This finding shows that 60% of the variation in protein 
levels can not be explained by knowing mRNA concentrations (Vogel and Marcotte, 2012). 
In addition, a modest correlation between mRNA and protein levels was reported for mouse 
(Ghazalpour et al., 2011). These data suggest that the concordance between transcriptome and 
proteome must not be taken for granted. Provided that cell function is dictated by proteins, 
immunohistochemistry is more reliable than the identification of genes, since it reveals the 
expression of proteins.  
The semiquantitative results of the Gpx1 protein expression at the spheno-occipital 
synchondrosis of the rat show that proliferative chondrocytes have the highest Gpx1 
immunoreactivity, followed by resting chondrocytes. The lowest levels of Gpx1 
immunoreactivity were identified in hypertrophic chondrocytes. Similar to the present 
findings, lower activity of SOD, Gpx4, and catalase has been reported for hypertrophic 
chondrocytes compared to other stages of chondrogenic differentiation (Matsumoto et al., 
1991; Fragonas et al., 1998). The lower expression of antioxidant enzymes leads to higher 
levels of ROS in hypertrophic compared to proliferating or resting chondrocytes, as 
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previously reported (Morita et al., 2007). NADPH oxidases 1 and 2 contribute to ROS levels 
during hypertrophy, since they were highly expressed in prehypertrophic and hypertrophic 
chondrocytes (Kim et al., 2010). Especially the depletion of NADPH oxidase 2 resulted in 
abnormal chondrogenic differentiation (Kim et al., 2010). Finally, ROS elevation inhibits 
proliferation and initiates hypertrophy of chondrocytes (Morita et al., 2007). This could match 
the present results, as proliferating zones demonstrated the highest Gpx1 immunoreactivity 
and hypertrophic zones the lowest one. 
However, immunohistochemical detection is accompanied by specific limitations. It is 
considered a semiquantitative method based on observer’s visual scoring  and, as such, is 
subjective (Taylor and Levenson, 2006), which in turn leads to inter- and intra-observer 
variability. Nevertheless, although computer-assisted quantification works faster, it is not 
always associated with better results (Matos et al., 2006; Ong et al., 2010). In the present 
study, an effort was made to account for inter- and intra-observer variability. The inter-
observer agreement was found to be substantial and the intra-observer variability was not 
statistically significant. 
 
5.3. Gpx1 plays a vital role on H2O2-induced apoptosis in chondrocytes 
 
After determining the distribution pattern of Gpx1 protein expression at the spheno-occipital 
synchondrosis, the effect of Gpx1 on chondrocytes was investigated in vitro. Provided that 
Gpx1 catalyses the reaction 2GSH + H2O2 → GSSG + 2H2O (Kulinsky and Kolesnichenko, 
2009), ATDC5 cells were treated with 250 µM H2O2. To define the role of Gpx1 on H2O2 
scavenging, three groups were established: Gpx1-overexpressing cells, Gpx1-knockdown 
cells, and control cells. The apoptotic percentage of cells was then flow-cytometrically 
measured with FITC-labelled Annexin V in conjunction with PI dye. 
Annexin V as a means to detect apoptosis was first described by Koopman et al. (1994). It 
demonstrates high affinity to membrane phospholipid phosphatidylserine (Andree et al., 
1990), which is translocated from the internal to the external cellular environment (Fadok et 
al., 1992) in apoptotic cells. The PI dye is simultaneously used for discriminating between 
dead and apoptotic cells (van Engeland et al., 1998). This procedure has certain advantages, 
one of the most important being the detection of the early stages of apoptosis through changes 
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of the cell surface. DNA-associated changes occur  rather late in apoptosis and assays 
detecting those changes are thus less precise than Annexin V (Zhang et al., 1997). Further, 
fluorescence of the samples was quantified with flow cytometry. Flow cytometry is an 
accurate method for quantifying fluorescence and presents advantages over fluorescence 
microscopy, namely flow cytometry is more objective, reproducible, and sensitive (Bolaños et 
al., 1988; Torous et al., 2003; Muratori et al., 2008). 
Results obtained with the aforementioned method revealed that Gpx1 is necessary for 
chondrocytes, since Gpx1-depleted chondrocytes essentially underwent apoptosis at the 
highest percentage under H2O2 exposure. On the contrary, Gpx1-overexpressing chondrocytes 
had the lowest apoptotic percentage. These results are suggestive of the vital role of Gpx1 on 
H2O2 scavenging and, consequently, H2O2-induced apoptosis in chondrocytes. 
However, Gpx1 is not the only one source of H2O2 degradation. Catalase  also belongs to the 
antioxidant enzymatic defence system and reduces H2O2 according to the following reaction: 
2H2O2 → 2H2O + O2 (Kalyanaraman, 2013). Therefore, the role of catalase on H2O2-induced 
apoptosis needs elucidation in chondrocytes, although catalase was shown to be inactivated 
(Lardinois et al., 1996; Baud et al., 2004) in the presence of high concentrations of H2O2. In 
addition to this, catalase seemed to be dependent on Gpx1 activity to prevent its inactivation 
at high concentrations of H2O2 (Baud et al., 2004). 
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6. Summary 
 
Orthodontics deals with the correction of skeletal anomalies of the face occurring in the form 
of jaw discrepancies. There is an abundance of findings in the literature that the development 
and growth of the cranial base influence facial shape and jaw discrepancies. Cranial base 
develops by the mechanism of endochondral ossification taking place at its midline axis, 
where all the synchondroses are located. Chondrogenesis is the initial and indispensable part 
of endochondral bone formation. In the light of evidence underlying the need of reactive 
oxygen species in the regulation of chondrogenesis, this study aimed to investigate the 
ubiquitously present antioxidant enzyme Gpx1 and its contribution to redox regulation in 
chondrogenesis. 
Provided that the levels of oxidative stress were previously found to fluctuate according to the 
differentiation stage of chondrocytes, the gene expression of Gpx1 was measured with 
quantitative RT-PCR during chondrogenic differentiation. For this purpose, the chondrogenic 
cell line ATDC5 was utilized and cultured for 21 days. The time points of measurements were 
on days 0, 2, 6, 10, 14, and 21. The chondrogenic differentiation of the utilized cell line was 
determined with the stains Alcian blue and Alizarin red, and with the gene expression of 
chondrogenic biological markers Col2a1 and Col10a1. The present results suggest that the 
expression of Gpx1 is not of constitutive nature during chondrogenic differentiation. 
Taking this as a starting point, the next step was to quantitatively assess the distribution 
pattern of Gpx1 at the different differentiation stages of chondrogenesis. To examine this, the 
spheno-occipital synchondrosis from eight newborn male Wistar rats was isolated and 
samples were processed for formaldehyde-fixed paraffin-embedded immunohistochemistry. 
Photographs of the immunostained sections were analysed by two independent observers and 
a five-grade semiquantitative scale was used to assess Gpx1 immunoreactivity at the 
synchondrosis. The present findings show that Gpx1 is expressed the most at the proliferative 
differentiation stage and the lowest at the hypertrophic differentiation stage. Existing 
literature reports that an increase in oxidative levels is needed for inhibition of proliferation 
and initiation of hypertrophy. Further, chondrocytes at the hypertrophic stage have the highest 
levels of ROS compared to other differentiation stages. In this context, the present results 
implied that Gpx1 is involved in redox regulation in chondrogenesis. 
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To pursue this further, the expression of Gpx1 was manipulated in ATDC5 chondrogenic cells 
and cells were then exposed to exogenous H2O2. The manipulation of Gpx1 expression 
included overexpression and silencing. A control group was also included. The apoptotic 
percentage of cells was measured flow cytometrically with FITC-labelled Annexin V in 
conjunction with PI dye. The highest apoptotic percentage was observed in Gpx1-depleted 
chondrocytes, followed by the control group. The lowest apoptotic percentage was presented 
in Gpx1-overexpressing cells. These results indicate that Gpx1 possesses an active role on the 
cellular enzymatic antioxidant system of chondrocytes and can regulate the cellular redox 
state by H2O2 scavenging. Furthermore, its presence in chondrocytes can prevent H2O2-
induced apoptosis. 
The contribution of cranial base growth to craniofacial morphology continues until adulthood, 
since spheno-occipital synchondrosis is the last of the synchondroses to ossify and is active 
until then. This study localizes the expression of Gpx1 at the spheno-occipital synchondrosis 
and documents the role of Gpx1 as a redox regulator in chondrocytes. 
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7. Zusammenfassung 
 
Die Kieferorthopädie befasst sich mit der Prävention, Diagnostik und Therapie von 
Skelettanomalien des Gesichts, welche in Form von Kieferfehlstellungen auftreten. Eine Fülle 
von Forschungsergebnissen besagt, dass die Entwicklung und das Wachstum der Schädelbasis 
die Gesichtsform und damit Kieferfehlstellungen beeinflussen. Die Schädelbasis entwickelt 
durch den Mechanismus der enchondralen Ossifikation, die an ihrer mittleren Achse 
stattfindet, wo sich alle Synchondrosen befinden. Chondrogenese ist der erste und 
unverzichtbare Bestandteil der enchondralen Ossifikation. Angesichts der Beweise für die 
Notwendigkeit der reaktiven Sauerstoffspezies in der Regulation der Chondrogenese, sollte 
diese Studie das allgegenwärtig vorhandene antioxidative Enzym Gpx1 und dessen Beitrag 
zur Redoxregulation während der Chondrogenese untersuchen. 
Vorausgesetzt, dass das Niveau von oxidativem Stress entsprechend dem 
Differenzierungsstadium der Chondrozyten schwankt, wurde die Genexpression von Gpx1 
mit quantitativer RT-PCR während der chondrogenen Differenzierung gemessen. Zu diesem 
Zweck wurde die chondrogene Zelllinie ATDC5 verwendet und für 21 Tage kultiviert. Die 
Messzeitpunkte wurden an den Tagen 0, 2, 6, 10, 14 und 21 ausgewählt. Die chondrogene 
Differenzierung der verwendeten Zelllinie wurde mit den Färbungen Alcian-Blau und 
Alizarin-Rot bestimmt und mit der Genexpression von chondrogenen biologischen Markern 
Col2a1 und Col10a1 verglichen. Die vorliegenden Ergebnisse deuten darauf hin, dass die 
Expression von Gpx1 nicht von konstitutiver Natur während der chondrogenen 
Differenzierung ist.  
Auf dieser Basis wurde das Verteilungsmuster von Gpx1 in den verschiedenen 
Differenzierungsstadien der Chondrogenese näher untersucht. Die Synchondrosis spheno-
occipitalis wurde aus acht neugeborenen männlichen Wistar-Ratten isoliert. Die Proben 
wurden für Formaldehyd-fixierte und Paraffin-eingebettete Immunhistochemie 
weiterverarbeitet. Eine fünfstufige semiquantitative Skala wurde verwendet, um die Gpx1-
Immunreaktivität bei der Synchondrosis spheno-occipitalis zu bestimmen. Fotografien der 
immungefärbten Abschnitte wurden von zwei unabhängigen Beobachtern bewertet. Die 
vorliegenden Ergebnisse zeigen, dass Gpx1 am meisten bei den proliferativen Chondrozyten 
und am wenigsten bei den hypertrophen Chondrozyten exprimiert wird. Existierende Literatur 
berichtet, dass eine Erhöhung des oxidativen Niveaus für die Hemmung der Proliferation und 
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die Einleitung der Hypertrophie nötig ist. Weiterhin weisen Chondrozyten im hypertrophen 
Stadium das höchste Niveau von ROS im Vergleich zu anderen Differenzierungsstadien auf. 
In diesem Zusammenhang implizierten die vorliegenden Ergebnisse, dass Gpx1 an der 
Redoxregulation während der Chondrogenese beteiligt ist. 
Um dies weiter zu verfolgen, wurde die Expression von Gpx1 in ATDC5 chondrogenen 
Zellen manipuliert und Zellen wurden dann exogenem H2O2 ausgesetzt. Die Manipulation der 
Gpx1-Expression enthielt Überexpression und Silencing. Eine Kontrollgruppe wurde 
ebenfalls eingeschlossen. Der apoptotische Prozentsatz der Zellen wurde 
durchflusszytometrisch mit FITC-Annexin V und -Propidiumiodid-Färbung gemessen. Der 
höchste apoptotische Prozentsatz wurde in Gpx1-ausgeschalteten Chondrozyten beobachtet, 
gefolgt von der Kontrollgruppe. Der niedrigste apoptotische Prozentsatz wurde in Gpx1-
überexprimierenden Zellen präsentiert. Diese Ergebnisse zeigen, dass Gpx1 eine aktive Rolle 
im zellulären enzymatischen Antioxidationssystem der Chondrozyten besitzt und den 
zellulären Redoxzustand durch H2O2-Abbau regeln kann. Darüber hinaus kann seine Präsenz 
in Chondrozyten H2O2-induzierte Apoptose verhindern.  
Der Einfluss des Schädelbasiswachstums auf die kraniofaziale Morphologie bleibt bis ins 
frühe Erwachsenenalter bestehen, da die Synchondrosis spheno-occipitalis bis dahin aktiv 
bleibt. Diese Studie lokalisiert die Expression von Gpx1 an der Synchondrosis spheno-
occipitalis und dokumentiert die Rolle von Gpx1 als Redox-Regler in Chondrozyten. 
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